Caffeine Accelerates Emergence from Isoflurane Anesthesia in Humans: A Randomized, Double-blind, Crossover Study.
Caffeine Accelerates Emergence from Isoflurane Anesthesia in Humans: A Randomized, Double-blind, Crossover Study.
复制标题
DOI:
10.1097/aln.0000000000002367
复制
发表时间:
2018-11
期刊:
影响因子:
8.8
通讯作者:
Xie Z
中科院分区:
文献类型:
--
作者:
Fong R;Wang L;Zacny JP;Khokhar S;Apfelbaum JL;Fox AP;Xie Z
There are currently no drugs clinically available to reverse general anesthesia. We previously reported that caffeine is able to accelerate emergence from anesthesia in rodents. This study was carried out to test the hypothesis that caffeine accelerates emergence from anesthesia in humans. We conducted a single-center, randomized, double-blind crossover study with 8 healthy males. Each subject was anesthetized twice with 1.2% isoflurane for 1 hour. During the final 10 minutes of each session, participants received an intravenous infusion of either caffeine citrate (15 mg/kg - equivalent to 7.5 mg/kg of caffeine base) or saline placebo. The primary outcome was the average difference in time to emergence after isoflurane discontinuation between caffeine and saline sessions. Secondary outcomes included the end-tidal isoflurane concentration at emergence; and vital signs and bispectral index values measured throughout anesthesia and emergence. Additional endpoints related to data gathered from post-anesthesia psychomotor testing. All randomized participants were included in the analysis. The mean time to emergence with saline was 16.5 ± 3.9 (SD) minutes compared to 9.6 ± 5.1 (SD) minutes with caffeine (p =0.002), a difference of 6.9 minutes ([1.8 to 12; 99% CI]), a 42% reduction. Participants emerged at a higher expired isoflurane concentration, manifested more rapid return to baseline BIS values, and were able to participate in psychomotor testing sooner when receiving caffeine. There were no statistically significant differences in vital signs with caffeine administration and caffeine related adverse events. Intravenous caffeine is able to accelerate emergence from isoflurane anesthesia in healthy males without any apparent adverse effects.